| Client | The Christie NHS Foundation Trust / Interserve / VINCI |
|---|---|
| Turley office | Manchester |
| Status | Constructed and operational |
| LPA | Manchester City Council |
Working with The Christie NHS Foundation Trust, “The Christie”, to create a world-class cancer research building
Our role
- Our trusted Planning advice with integrated support from our expert service teams has led to success across a number of complex planning applications including the world-renowned Proton Beam Therapy Centre at The Christie.
- A multi-service team advised The Christie on the Paterson Redevelopment Project (PRP) through a number of project stages. This included the preparation of a Strategic Planning Framework (SPF) to establish the principles of the replacement building and a detailed planning application.
- In addition to co-ordinating a multi-disciplinary team in the production of the planning application, we also led the production of the Enviornmental Impact Assessment (EIA).
- We designed and implemented the strategy for proactive and ongoing engagement with The Christie Neighbourhood Forum, local neighbours, strategic stakeholders and the wider Greater Manchester community leading to wide-reaching support for the project.
Results
- The SPF was endorsed in July 2019 by the Council’s Executive.
- A key aspect of this application was the strategic economic case and ‘Case for Team Science’ underpinning the scientific justification for the scheme. Our Economics team worked in collaboration with The Christie and its partners to prepare robust evidence to demonstrate that it is a unique development opportunity and one that will benefit patients, local residents and the Greater Manchester economy.
- The planning application for The Paterson Redevelopment Project (PRP) was approved in September 2019 and it opened in 2024. The PRP is now a world-class research facility which is transforming the ability to prevent, diagnose and treat cancer through the co-location of clinicians and scientists in a single building, an approach known as Team Science. The PRP is led by The Christie on behalf of the Manchester Cancer Research Centre, a decade-long partnership between The Christie, The University of Manchester and Cancer Research UK.